Discordant association of the CREBRF rs373863828 minor allele with increased body mass index and protection from type 2 diabetes in Maori and Pacific (Polynesian) people living in Aotearoa New Zealand
Mohanraj KrishnaniD, Tanya J. MajoriD, Ruth ToplessiD, Ofa DewesiD, Lennex Hsueh‐Lin YuiD, John ThompsoniD, Lesley M. E. McCowaniD, Janak de ZoysaiD, Lisa K. StampiD, Nicola DalbethiD, Jennie Harré Hindmarsh, Nuku Rapana, Ranjan DekaiD, Winston W. H. EngiD, Daniel E. WeeksiD, Ryan L. MinsteriD, Stephen T. McGarveyiD, Satupaitea VialiiD, Take K. NaseriiD, Muagututi‘a Sefuiva ReupenaiD, Phillip G. WilcoxiD, David Ross GrattaniD, Peter Robin ShepherdiD, Andrew Neil ShellingiD, Rinki MurphyiD, Tony Raymond MerrimaniD
Abstract
Aim/HypothesesThe minor allele of CREBRF rs373863828 associates with increased body mass index (BMI) and reduced risk of type 2 diabetes (T2D) in the Samoan population of Samoa and American Samoa. Our aim was to test rs373863828 for association with BMI and odds of T2D, gout and chronic kidney disease (CKD) in M[a]ori and Pacific (Polynesian) people living in Aotearoa New Zealand in 2,286 adults.\n\nMethodsAssociation analyses were performed by linear and logistic regression with BMI, log-transformed BMI, waist circumference, T2D, gout and CKD. Analyses were adjusted for age, sex, the first four genome-wide principal components, and (when appropriate) BMI, waist circumference and T2D.\n\nResultsFor the minor allele of rs373863828 the effect size for log-transformed BMI was 0.038 (95% CI [0.022-0.055], P=4.8x10-6) and for T2D was OR=0.59 (95% CI [0.47-0.73], P=1.9x10-6). There was no evidence for association of genotype with variance in BMI (P=0.13). Nor was there evidence for association with serum urate ({beta}=0.012 mmol/L, Pc=0.10), gout (OR=1.00, P=0.98) or CKD (OR=0.91, P=0.59).\n\nConclusions/interpretationOur results replicated, with very similar effect sizes, association of the minor allele of rs373863828 with higher BMI but lower odds of T2D among New Zealand Polynesian adults, as in Samoan adults living in Samoa and American Samoa.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 75
- FWCI
- 1.27
- Field percentile
- top 20%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- CREBRF missense variant rs373863828 has both direct and indirect effects on type 2 diabetes and fasting glucose in Polynesians living in Samoa and Aotearoa New Zealand.
Emily M. Russell, Jenna C. Carlson, … Ryan L. Minster·BMJ Open Diabetes Research & CarePeer-reviewed·Feb 1, 2022
- A missense variant in CREBRF is associated with taller stature in Samoans
Jenna C. Carlson, Samantha L. Rosenthal, … Ryan L. Minster·American Journal of Human BiologyPeer-reviewed·Mar 19, 2020
- CREBRF rs373863828 minimally regulates gene expression in subcutaneous adipose tissue of Samoan adults
Samantha L. Manna, Anna C. Rivara, … Zsolt Urbán·medRxiv·Sep 22, 2026
- Non-obese population with the rs7903146 T allele exhibits higher sugar and more dyslipidaemia in subjects with Type-2-diabetes
Sarah Shaibu, Ishaya Yohanna Longdet, … Samuel Eneọjọ Abah·medRxiv·Sep 9, 2020
- BMI inadequately mediates the relationship between polygenic risk of adiposity and early onset type 2 diabetes in south Asians
Binur Orazumbekova, Julia Zöllner, … Moneeza Kalhan Siddiqui·medRxiv·Jun 12, 2025
- Meta-analysis of over 8,000 individuals from Hawai'i and Samoa for genetic associations to cardiometabolic phenotypes
Bryan L. Dinh, Xinran Wang, … Jenna C. Carlson·medRxiv·May 12, 2026